MedTrace Logo

Analysis of TPE Treatments With multiFiltratePRO

NCT06272084 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-08-28

No results posted yet for this study

Summary

Analysis of therapeutic plasma exchange (TPE) treatments to assess the performance of the TPE mode of multiFiltratePRO based on the successful exchange of plasma from whole blood. The multiFiltratePRO is a device for extracorporeal blood purification treatments.

Conditions

Interventions

DEVICE

Therapeutic Plasma Exchange (TPE) option of multiFiltratePRO

Retrospective Data Analysis of TPE treatments with multiFiltratePRO

Sponsors & Collaborators

  • X-act Cologne Clinical Research GmbH

    collaborator INDUSTRY

  • Fresenius Medical Care Deutschland GmbH

    lead INDUSTRY

Principal Investigators

  • Stefan Büttner, Dr. med. · Klinikum Aschaffenburg-Alzenau

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-22
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06272084 on ClinicalTrials.gov